AstraZeneca beats third-quarter expectations, maintains outlook

AstraZeneca beat third-quarter earnings expectations on Thursday, helped by strong sales of its cancer, heart and kidney ...

AstraZeneca holds forecasts as cancer, heart drugs lift earnings

AstraZeneca beat expectations for third quarter earnings on Thursday with strong sales of its blockbuster cancer and ...
Investing.com Australia

LivaNova shares rise 2% as third-quarter results beat expectations

LivaNova’s Cardiopulmonary segment led growth with an 18% revenue increase to $203.2 million compared to the same period last year, driven by strong sales of its Essenz Perfusion System and robust ...

AGL Q3 Deep Dive: Revenue Beats Expectations Amid Profitability Challenges and Strategic Realignment

Healthcare services company Agilon Health (NYSE:AGL) announced better-than-expected revenue in Q3 CY2025, but sales fell by 1 ...

Edwards Lifesciences beats quarterly estimates on strength in heart devices

Edwards Lifesciences beat Wall Street estimates for third-quarter results on Thursday, driven by strong demand for its artificial heart valves and other medical devices, with shares rising about 3% in ...

AstraZeneca beats Q3 expectations, maintains FY outlook

Drugmaker AstraZeneca reiterated its full-year guidance on Thursday as it posted a third-quarter earnings beat, driven by ...